Alembic Pharma Reports USFDA Warning Letter To Investigator With 0 Impact On Data Reliability

FDA warns Florida supplement maker about sanitation and allergen risks

As part of its enforcement activities, the U.S. Food and Drug Administration sends warning letters to entities under its jurisdiction. Some

Pfizer Aktie: FDA lässt PADCEV-Kombi zu

Die US-Gesundheitsbehörde FDA hat die Kombination aus PADCEV und Keytruda für die Behandlung von Patienten mit muskelinvasivem Blasenkrebs (

U.S. Clinical Trial Design & Execution Risks

FDA warns it will reject test results from three third-party labs due to ‘unreliable’ data

The FDA says it will reject all data from studies conducted at a Chinese third-party testing facility due to unreliable data. It’s the lates

RFK Jr. pushes peptide deregulation; FDA scientists cite lack of safety evidence

The health secretary has advocated for deregulating more peptides, but FDA scientists point to a lack of data about their safety and effecti

FDA Explores Expediting Clinical Trials: Announces Ambitious New Drug Pilot Program

On June 24, 2026, the Food and Drug Administration (FDA) published a notice of availability in the Federal Register requesting information a